Completed PHASE1 INTERVENTIONAL NCT00400556

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

A Phase I Study of Haematopoietic Stem Cell Mobilization Using G-CSF With ATRA in Patients With Cutaneous Lymphoma and Multiple Myeloma

Sponsor: Peter MacCallum Cancer Centre, Australia

Conditions Cutaneous Lymphoma Multiple Myeloma

Interventions ATRA plus G-CSF (filgrastim, NEUPOGEN (R)) combination

Updated 4 times since 2017 Last updated: Nov 15, 2006 Started: Mar 31, 2005 Completion: May 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00400556, this PHASE1 trial focuses on Cutaneous Lymphoma and Multiple Myeloma and remains completed. Sponsored by Peter MacCallum Cancer Centre, Australia, it has been updated 4 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Data source: Peter MacCallum Cancer Centre, Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• East Melbourne, Australia